NCT02428582

Brief Summary

To compare the outcome of revascularisation the gastrointestinal arteries using covered stents compared to bare-metal stents in patients with CGI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 29, 2015

Completed
1 year until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

5.5 years

First QC Date

April 15, 2015

Last Update Submit

March 8, 2021

Conditions

Keywords

endovascular treatmentarterial occlusive diseasebare metal stentpolytetrafluoroethylene covered stent

Outcome Measures

Primary Outcomes (1)

  • The difference of primary and secondary patency rates of covered stents versus bare-metal stents to treat atherosclerotic CGI disease.

    12 to 24 months

Secondary Outcomes (5)

  • The freedom from restenosis after 6-, 12- and 24- months after stent implantation

    6 to 24 month

  • The freedom from symptom recurrence after 6-, 12- and 24- months after stent implantation

    6 to 24 month

  • The freedom from reintervention after 6-, 12- and 24- months after stent implantation

    6 to 24 month

  • The clinical outcome in terms of quality of life and therapeutic and total costs after 6-, 12- and 24- months after stent implantation

    6 to 24 month

  • The clinical outcome in terms therapeutic and total costs after 6-, 12- and 24- months after stent implantation

    6 to 24 month

Study Arms (2)

bare stent inserted

ACTIVE COMPARATOR

Standard bare stent will be placed

Device: Bare stent (Brand Cordis Type Palmaz Blue)

Covered stent inserted

EXPERIMENTAL

Covered stent will be placed

Device: Covered stent (Atrium Type V12)

Interventions

An endovascular treatment that consists of inserting a covered stent into the stenosed vessels.

Covered stent inserted

An endovascular treatment that consists of inserting a stent into the stenosed vessels.

Also known as: Brand Cordis Type Palmaz Blue
bare stent inserted

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with consensus diagnostic of CGI based on a clinical meeting with a gastroenterologist, a vascular surgeon and an interventional radiologist.
  • Diagnostic consensus of CGI is based on.
  • Presence of postprandial pain
  • Unexplained weight loss (\>5% of normal body weight).
  • Significant stenosis of \>50% of at least one of the gastrointestinal arteries on a recent CTA (Computer Tomographic Angiography) not older than one year, with maximum slice thickness 1 mm and enhancement in aorta of 300HU (Hounsfields Units)
  • Mucosal ischemia detected by VLS (Visible Light Spectroscopy) or tonometry
  • Patients over the age of 18 years.
  • Patients who gave informed consent.
  • Patients have sustained atherosclerosis.

You may not qualify if:

  • Patients who don't give informed consent.
  • Age \< 18 years
  • No stenosis detected during arteriography.
  • Renal insufficiency (GFR below 30 ml/min or GFR below 60 ml/min when comorbidities relevant to kidney function present).
  • Previous stent placement in the to be treated gastrointestinal artery.
  • Pregnancy
  • Celiac artery compression syndrome.
  • Vasculitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ErasmusMC

Rotterdam, South Holland, 3015CE, Netherlands

Location

Related Publications (2)

  • Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS, Fioole B, Harki J, van den Heuvel DAF, Hinnen JW, Kolkman JJ, Nikkessen S, van Petersen AS, Smits HFM, Verhagen HJM, de Vries AC, de Vries JPM, Vroegindeweij D, Geelkerken RH, Bruno MJ, Moelker A; Dutch Mesenteric Ischemia Study Group. Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):299-309. doi: 10.1016/S2468-1253(23)00402-8. Epub 2024 Jan 29.

  • van Dijk LJD, Harki J, van Noord D, Verhagen HJM, Kolkman JJ, Geelkerken RH, Bruno MJ, Moelker A; Dutch Mesenteric Ischemia Study group (DMIS). Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol for a randomized controlled trial. Trials. 2019 Aug 20;20(1):519. doi: 10.1186/s13063-019-3609-8.

MeSH Terms

Conditions

ArteriosclerosisMental DisordersConstriction, PathologicNecrosisArterial Occlusive Diseases

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Adriaan Moelker, dr

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinating trialbureau

Study Record Dates

First Submitted

April 15, 2015

First Posted

April 29, 2015

Study Start

May 1, 2016

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

March 9, 2021

Record last verified: 2021-03

Locations